Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
Sell
-7,600
Closed -$383K 4073
2014
Q2
$383K Hold
7,600
﹤0.01% 3707
2014
Q1
$335K Sell
7,600
-21,700
-74% -$1.03M ﹤0.01% 3856
2013
Q4
$1.19M Sell
29,300
-11,400
-28% -$421K ﹤0.01% 3014
2013
Q3
$1.37M Buy
+40,700
New +$1.32M ﹤0.01% 2757

Other funds holding ALKS

David Shaw's ALKS Position: Q2 2026 in Review

David Shaw increased its Alkermes (ALKS) stake by 85% in Q2 2026, buying an estimated $23.5M and bringing the position to 1,312,031 shares worth $68.7M. The position accounts for 0.03% of the portfolio, ranked #604.

David Shaw first reported a position in ALKS in Q2 2013 and has held it in 53 quarters since. The position peaked at $78.3M in Q3 2016. 422 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • David Shaw held 1,312,031 shares of Alkermes worth $68.7M as of Q2 2026.
  • David Shaw bought 601,734 Alkermes shares in Q2 2026, an estimated $23.5M.
  • Alkermes made up 0.03% of David Shaw's portfolio in Q2 2026, its #604 holding.
  • David Shaw first reported a position in Alkermes in Q2 2013 and has held it in 53 quarters since.
  • David Shaw's Alkermes position peaked at $78.3M in Q3 2016.
  • 422 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.